Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

Jan-Dirk Vermeij, Paul J. Nederkoorn, Yvo B. Roos

Research output: Contribution to journalComment/Letter to the editorAcademic

1 Citation (Scopus)

Abstract

To the Editor: Wechsler (June 2 issue)(1) presents a case vignette of an 81-year-old patient who arrived in the emergency department after the apparent onset of a major left hemispheric ischemic stroke about an hour earlier. After the diagnosis was confirmed on imaging, therapy with intravenous recombinant tissue plasminogen activator (rt-PA) was initiated. Timely recanalization of the occluded artery is the only effective treatment for acute ischemic stroke (i.e., time is brain). Intravenous thrombolytic therapy is approved by the Food and Drug Administration in such patients. However, the effectiveness of such therapy in large and midsize arteries is limited, and . .
Original languageEnglish
Pages (from-to)965-966
JournalNew England journal of medicine
Volume365
Issue number10
DOIs
Publication statusPublished - 2011

Cite this